TrialDrugs in R&D2024

Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants.

Shan Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.